K. Parkhurst

Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies

A. Sood, R. Kurzrock, A. Naing, 2013, Investigational New Drugs.

A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer

R. Kurzrock, F. Janku, A. Naing, 2014, Investigational New Drugs.

Targeting hypoxia-inducible factor-1α (HIF-1α) in combination with antiangiogenic therapy: A phase I trial of bortezomib plus bevacizumab

K. Hess, C. Ng, E. Jackson, 2014, Oncotarget.

Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors

R. Kurzrock, F. Janku, A. Naing, 2014, Investigational New Drugs.

Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors

K. Hess, R. Kurzrock, V. Prieto, 2016, Archives of Dermatological Research.